In this study, we propose a new feature (or gene) selection algorithm using Bayes classification approach. The algorithm can find gene subset crucial for cancer classification problem. Problem statement: Gene identification plays important role in human cancer classification problem. Several feature selection algorithms have been proposed for analyzing and understanding influential genes using gene expression profiles. Approach: The feature selection algorithms aim to explore genes that are crucial for accurate cancer classification and also endure biological significance. However, the performance of the algorithms is still limited. In this study, we propose a feature selection algorithm using Bayesian classification approach. Results: This approach gives promising results on gene expression datasets and compares favorably with respect to several other existing techniques. Conclusion: The proposed gene selection algorithm using Bayes classification approach is shown to find important genes that can provide high classification accuracy on DNA microarray gene expression datasets.
INTRODUCTION
The classification of tissue samples into one of the several classes or subclasses using their gene expression profile is an important task and has been attracted widespread attention (Sharma and Paliwal, 2008) . The gene expression profiles measured through DNA microarray technology provide accurate, reliable and objective cancer classification. It is also possible to uncover cancer subclasses that are related with the efficacy of anti-cancer drugs that are hard to be predicted by pathological tests. The feature selection algorithms are considered to be an important way of identifying crucial genes. Various feature selection algorithms have been proposed in the literature with some advantages and disadvantages (Sharma et al., 2011b; Tan and Gilbert, 2003; Cong et al., 2005; Golub et al., 1999; Wang et al., 2005; Li and Wong, 2003; Thi et al., 2008; Yan and Zheng, 2007; Sharma et al., 2011a) . These methods select important genes using some objective functions. The selected genes are expected to have biological significance and should provide high classification accuracy. However, on many microarray datasets the performance is still limited and hence the improvements are necessitated.
In this study, we propose a feature selection algorithm using Bayesian classification approach. The proposed scheme begins at an empty feature subset and includes a feature that provides the maximum information to the current subset. The process of including features is terminated when no feature can add information to the current subset. The bays classifier is used to judge the merit of features. It is considered to be the optimum classifier. However, the bays classifier using normal distribution could suffer from inverse operation of sample covariance matrix due to scarce training samples. However, this problem can be resolved by regularization techniques or pseudo inversing covariance matrix. The proposed algorithm is experimented on several publically available microarray datasets and promising results have been obtained when compared with other feature selection algorithms. ω and a priori probability P(ω j ). If we assume that the parametric distribution is normal then a posteriori probability can be defined as Eq. 1:
where, ĵ µ is the centroid and ĵ Σ the covariance matrix
(which is applied when ĵ Σ is a singular matrix). If m < n then ĵ Σ will be a non-singular matrix and therefore
The training set χ can be partitioned into a smaller portion of training set χ tr and validation set χ val . The set χ tr can be used to evaluate the parameters of equation 1 (i.e., ĵ µ and ĵ Σ ) and the set χ val can be used to compute classification accuracy (or misclassification error) for the feature vectors defined by the subset s. The procedure of finding feature subset is described in the following algorithm:
Algorithm:
Step 0: Define feature set f = {f 1 , f 2 ,…f d } and initialize s = {} as empty set.
Step 1: Given the training feature vectors χ , partition it randomly into two segments χ tr and χ val using partitioning ratio r (we allocate approximate 60% of samples to χ tr and the remaining in the other segment).
Step 2: Take feature subset s ∪ f k (for k =1, 2, …,d) at a time and compute for this feature subset the training parameters ĵ µ and ĵ Σ on χ tr segment.
Step 3: By using Eq. 1, compute classification accuracy α k using feature subset s ∪ f k on χ val segment.
Step 4: Repeat Steps 1-3 N times (we use N = 10) to get an average classification accuracy k α (for k = 1, 2, …, d).
Step 5: Allocate the feature to the subset s which gives highest k α , i.e., k p arg max = α and include f p in subset s; i.e., s ⇐ s∪ f p . If two or more features are giving equal average classification accuracy then select f p which is individually giving the highest accuracy.
Step 6: Exclude feature f p from the feature set f and go to Step 1 to find the next best feature until the average classification accuracy reaches the maximum (i.e.,
where k (q) α is the average classification accuracy at q th iteratation).
The above algorithm will give a subset of features. However, if more than one subset of features is required then the procedure should be repeated on the remaining features. Next, we describe materials and method.
MATERIALS AND METHODS
Publicly available DNA microarray gene expression datasets are used from Kent Ridge Biomedical repository (http://datam.i2r.astar.edu.sg/datasets/krbd/). The program code is written in Matlab on i7 dual-core Pentium processor in Linux environment.
RESULTS
In the experimentation 3 DNA microarray gene expression datasets have been used. The description of the datasets is given as follows.
Acute leukaemia dataset (Golub et al., 1999) : This dataset consists of DNA microarray gene expression data of human acute leukaemia for cancer classification. Two types of acute leukaemia data are provided for classification namely Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML). The dataset is subdivided into 38 training samples and 34 test samples. The training set consists of 38 bone marrow samples (27 ALL and 11 AML) over 7129 probes. The test set consists of 34 samples with 20 ALL and 14 AML, prepared under different experimental conditions. All the samples have 7129 dimensions and all are numeric.
Lung dataset (Gordon et al., 2002) : This dataset contains gene expression levels of Malignant Mesothelioma (MPM) and adenocarcinoma (ADCA) of the lung. There are 181 tissue samples (31 MPM and 150 ADCA). The training set contains 32 samples, 16 MPM and 16 ADCA. The rest of 149 samples are used for testing. Each sample is described by 12533 genes.
Breast cancer dataset ( Van't et al., 2002) : This is a 2 class problem with 78 training samples (34 relapse and 44 non-relapses) and 19 test samples (12 relapse and 7 non-relapses) of relapse and non-relapse. The dimension of breast cancer dataset is 24481.
The proposed algorithm is used for feature selection. For classification of test samples we use Bayesian classifier (using Eq. 1) and Linear Discriminant Analysis (LDA) technique using Nearest Centroid Classifier (NCC) with Euclidean distance measure. The identified genes from all the three datasets are described in Table 1 . Their corresponding classification accuracies on TRAIN data are also given. The biological significance of the identified genes is depicted in the last column of the table under p-value statistics using Ingenuity Pathways Analysis (IPA, http://www.ingenuity.com) tool. For acute leukemia dataset the highest classification accuracy on training set is obtained at 2nd iteration which is 100%; for lung cancer dataset, 100% classification accuracy is obtained at the 1st iteration; and, for breast cancer dataset, highest classification accuracy 95% is obtained at the 7th iteration. The proposed algorithm is compared with several other existing techniques on DNA microarray gene expression datasets. The performance (in terms of classification accuracy) of various techniques is depicted in Table 2 . It can be observed that the proposed method is giving high classification accuracy on very small number of selected features. # Selected genes on TEST data) (%) Prediction strength+ SVMs (Furey et al., 2000) 25-1000 88-94 Discretization + decision rules (Tan and Gilbert, 2003) 1038 91 RCBT (Cong et al., 2005) 10-40 91 Neighbourhood analysis + weighted 50 85 voting (Golub et al., 1999) CBF + decision trees (Wang et al., 2005) Lung cancer Discretization + decision trees (Tan and Gilbert, 2003) 5365 93 Boosting (Li and Wong, 2003) unknown 81 Bagging (Li and Wong, 2003) unknown 88 RCBT (Cong et al., 2005) 10-40 98 C4.5 (Li and Wong, 2003 
